Friday, August 13, 2010 11:32:02 AM
I bet the numbers that count will not be so much in the revenue but in the debt, as in "debt reduction"...or at least a good understanding of what the debt is for.
Advertizing is quite understandable.
340K in debt last time is not a big deal, especially at this pps and this A/S.
Advertizing is quite understandable.
340K in debt last time is not a big deal, especially at this pps and this A/S.
Recent CUBT News
- Curative Biotechnology Advances Translational Ophthalmology Program Through PennVet Research Agreement • GlobeNewswire Inc. • 05/07/2026 11:00:00 AM
- Curative Biotechnology Engages Sterling Pharmaceutical Services to Manufacture Clinical Supply of Metformin Topical Ophthalmic Therapy • GlobeNewswire Inc. • 04/15/2026 12:08:00 PM
- Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting • GlobeNewswire Inc. • 03/23/2026 11:05:00 PM
- Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting • GlobeNewswire Inc. • 03/23/2026 11:00:00 AM
- Curative Biotechnology Announces Canadian Patent Allowance • GlobeNewswire Inc. • 01/23/2026 01:45:00 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 12/22/2025 06:40:01 PM
- Curative Biotechnology, Inc. Announces Letter to Shareholders • GlobeNewswire Inc. • 11/18/2025 01:15:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/01/2025 08:07:47 PM
